Esteem
Envoy Medical Corporation · Decision date Oct 15, 2026
What did the FDA decide?
The FDA recorded a 30-Day Notice decision, OK30, dated 2026-10-15, for supplement P090018/S044 to the Esteem® device from Envoy Medical Corporation. The Esteem is an active, totally implanted middle-ear hearing implant (product code OAF, Ear, Nose, Throat specialty). The supplement reason is recorded as a process change affecting a manufacturer, sterilizer, packager or supplier.
The recorded change concerns the feedthroughs: manufacturing work instructions are revised to add a cutting step for the feedthroughs, intended to reduce resonant frequency fatigue in the feedthrough pins, and to add a visual inspection step to screen for feedthrough cracks. This is a supplement-level process change, not a new approval of the whole implant system. The source record does not include supporting documents, so the review basis and any conditions of the decision remain unknown.
Whether the added steps fully address feedthrough fatigue and crack risk is not established by this record, and no clinical or performance conclusions should be drawn from it.
FDA approval order statement
revising manufacturing work instructions to add a cutting step for the feedthroughs, to mitigate resonant frequency fatigue in the feedthrough pins, and to add an additional visual inspection step to screen for feedthrough cracks
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ear, Nose, Throat
- Decision date
- Oct 15, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P090018/S044
- Regulatory pathway
- PMA supplement
- Applicant
- Envoy Medical Corporation
- Product code
- OAF
- Decision code
- OK30
- Decision date
- Oct 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implant, hearing, active, middle ear, totally implanted.
- Applicant
- Envoy Medical Corporation
- Product code
- OAF
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P090018. Subsequent supplements may change the device or its indications.
FDA decision timeline
P090018 · Original PMA
ESTEEM TOTALLY IMPLANTABLE HEARING SYSTEM
P090018/S044 received
Application receipt date recorded by FDA.
P090018/S044 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P090018. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P090018
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Envoy Medical Corporation | PMA approval | Mar 17, 2010 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Envoy Medical Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 4875 White Bear Pkwy., White Bear Lake, MN, 55110
Sources and methodology
- Original FDA record: P090018/S044
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records